?N1-Methylnicotinamide: An Anti-Ovarian Aging Hormetin
N1-Methylnicotinamide: An Anti-Ovarian Aging Hormetin?
نویسندگان: حمیدرضا نجابتی , وحیده شهنازی , دنیز صمیمی فر , یوسف فریدوند , زهرا بهرامی , نازیلا فتحی معروفی , صبا نیکان فر , محمد نوری
کلمات کلیدی: Ovarian Aging
ROS
AMPK
MNAM
نشریه: 1178 , 101131 , 62 , 2020
| نویسنده ثبت کننده مقاله |
محمد نوری |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز سلولهای بنیادی |
| کد مقاله |
72971 |
| عنوان فارسی مقاله |
?N1-Methylnicotinamide: An Anti-Ovarian Aging Hormetin |
| عنوان لاتین مقاله |
N1-Methylnicotinamide: An Anti-Ovarian Aging Hormetin? |
| ناشر |
9 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Review Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Ovarian aging occurs due to the reduction of the quality and quantity of the oocytes, and is regulated by mitochondrial
survival and apoptotic signals. Reactive Oxygen Species (ROS) are one of those signals considered
detrimental to cellular homeostasis. Nowadays, ROS are regarded as a regulatory factor at low levels as it
induces the stress resistance which in turn increases the longevity. It is believed that the main mechanism for the
life-promoting role of the ROS mediated by the 5' Adenosine Monophosphate-activated Protein Kinase (AMPK).
N1-Methylnicotinamide (MNAM) is well known for its anti-diabetic, anti-thrombotic, and anti-inflammatory
activity. Aldehyde oxidase 1 (AOX1) is a detoxifying enzyme, which metabolizes the MNAM and produces two
metabolites including N1-methyl-2-pyridone-5- carboxamide (2py) and N1-methyl-4-pyridone-3-carboxamide
(4py). The activity of AOX1 enhances the production of ROS and improves the longevity. It has been reported
that the MNAM could postpone the aging through the induction of low-level stress. It has been documented that
the production of MNAM is significantly higher in the cumulus cells of the patients with Polycystic Ovary
Syndrome (PCOS) and its administration on the rat model of PCOS has been shown to alleviate the hyperandrogenism
and successfully activate the ovarian AMPK. Therefore, it can be hypothesized that the anti-ovarian
aging effects of the MNAM are possibly based on the activation of AMPK through transient elevation of the ROS. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Nejabati.pdf | 1399/05/05 | 633537 | دانلود |